Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia
about
Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemiaNumber and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance.TET2 mutations were predictive of inferior prognosis in the presence of ASXL1 mutations in patients with chronic myelomonocytic leukemia.Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features.Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management.Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia.DNMT3A mutations are associated with inferior overall and leukemia-free survival in chronic myelomonocytic leukemia.Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing.Flow cytometry based monocyte subset analysis accurately distinguishes chronic myelomonocytic leukemia from myeloproliferative neoplasms with associated monocytosisMutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia.Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevance.EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental.Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML.Prognostic interaction between bone marrow morphology and SF3B1 and ASXL1 mutations in myelodysplastic syndromes with ring sideroblasts.ASXL1 frameshift mutations drive inferior outcomes in CMML without negative impact in MDS.Nuances of Morphology in Myelodysplastic Diseases in the Age of Molecular Diagnostics.Chronic myelomonocytic leukemia: molecularly contaminated, but not defined.Outcome of patient with high-risk chronic myelomonocytic leukemia, treated with decitabine prior to transformation to acute myeloid leukemia: A case report.Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms.Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents.Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia
P2860
Q26768600-4691B055-6CCA-46B6-9AA5-F6A47D3DE282Q37325016-D49C67E9-1C05-4A60-8AA8-FF069BF53BD9Q37345073-D5B2B791-9544-4709-B42F-77462E281F9CQ37636744-F0C14DBC-8E35-460F-BA64-D36761B9FCB3Q38835771-0FA498BD-F789-4A21-85D0-B4C66C7AD227Q40287451-D5BF0F8B-28F6-4807-A49D-04DA22E50CA9Q40544891-F03FDE3F-2017-430C-8AFB-8821963AD847Q40911131-7FDB4C5F-D6EE-4111-9299-BD578C584E23Q41316642-20D026AF-D40D-40D6-B9C3-85DA09834CDDQ47142099-C1B1A914-6151-48F1-A371-FED762AB7A7FQ48126564-E6D9165C-5F0E-44E5-ABB3-828B6DE4720FQ48190815-FDB84E0F-CC17-42F1-9B36-399D0F23C376Q48200944-7F90919E-B662-4996-B880-5064C31A6DEDQ49224959-28F53070-722D-4616-B532-CB9FABEB9C79Q49516382-02F828BE-B6A1-46E1-AFBC-06118496BE77Q51804731-720B4677-1447-4E5F-B830-0FDD7B6E9F06Q53125557-055C5C17-F572-4D92-AE8F-5341B44D7F87Q54979651-B129A658-C3BC-4D8A-993A-FA2044C5829EQ55356840-9431B943-1550-4BBF-B12B-52634B3A1585Q55363317-BE82610B-20EA-48DF-97D4-4D5E1FBA2BA5Q57212458-05508D05-54E3-4ED3-9406-F6362DC6E3FE
P2860
Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Prognostic interaction between ...... hronic myelomonocytic leukemia
@ast
Prognostic interaction between ...... hronic myelomonocytic leukemia
@en
type
label
Prognostic interaction between ...... hronic myelomonocytic leukemia
@ast
Prognostic interaction between ...... hronic myelomonocytic leukemia
@en
prefLabel
Prognostic interaction between ...... hronic myelomonocytic leukemia
@ast
Prognostic interaction between ...... hronic myelomonocytic leukemia
@en
P2093
P2860
P356
P1433
P1476
Prognostic interaction between ...... hronic myelomonocytic leukemia
@en
P2093
C A Hanson
M M Patnaik
P Vijayvargiya
R P Ketterling
P2860
P2888
P356
10.1038/BCJ.2015.113
P577
2016-01-15T00:00:00Z
P5875
P6179
1050362734